Showing 121 - 140 results of 1,165 for search '"proton therapy"', query time: 0.35s Refine Results
  1. 121
  2. 122

    The Advantage of Proton Therapy in Hypothalamic-Pituitary Axis and Hippocampus Avoidance for Children with Medulloblastoma by Saif Aljabab, MBBS, FRCPC, Shushan Rana, MD, Shadonna Maes, CMD, Avril O’Ryan-Blair, CMD, Jackie Castro, CMD, Jack Zheng, MD, Lia M. Halasz, MD, Phillip J. Taddei, PhD

    Published 2021-08-01
    “…The purpose of this pilot study was to determine whether hypothalamic-pituitary axis (HPA) and hippocampus avoidance (HPA-HA) with intensity-modulated proton therapy (IMPT) can potentially reduce this morbidity compared with standard x-ray CSI. …”
    Get full text
    Article
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132

    Optimization of proton therapy eye-treatment systems toward improved clinical performances by Eustache Gnacadja, Cédric Hernalsteens, Stewart Boogert, Quentin Flandroy, Carolina Fuentes, Laurence J. Nevay, Nicolas Pauly, Eliott Ramoisiaux, William Shields, Robin Tesse, Raphael Van Roermund, Marion Vanwelde

    Published 2022-02-01
    “…The treatment protocols of cancerous ocular diseases with proton therapy are well established, and dedicated eye-treatment systems can produce the clinical beam properties that meet the peculiar features required by eye-treatment modalities. …”
    Get full text
    Article
  13. 133

    Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection by Xiao-Yu Wu MD, Mei Chen MS, Lu Cao MD, Min Li PhD, Jia-Yi Chen MD

    Published 2024-02-01
    “…Yet, the optimal indications for proton therapy in breast cancer patients remain uncertain. …”
    Get full text
    Article
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139

    Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids by Max Naumann, Tabea Czempiel, Anna Jana Lößner, Kristin Pape, Elke Beyreuther, Steffen Löck, Stephan Drukewitz, Alexander Hennig, Cläre von Neubeck, Barbara Klink, Mechthild Krause, Doreen William, Daniel E. Stange, Rebecca Bütof, Antje Dietrich

    Published 2022-08-01
    “…To optimize neoadjuvant radiochemotherapy of pancreatic ductal adenocarcinoma (PDAC), the value of new irradiation modalities such as proton therapy needs to be investigated in relevant preclinical models. …”
    Get full text
    Article
  20. 140